| Overview |
|
| 🧬 What is Beta Glucan?
Beta glucan is a type of soluble fiber found in the cell walls of:
-
Bacteria, fungi, yeasts, algae, lichens
-
Grains like barley and oats
🌾 Common Sources
-
Yeast: Most researched; powerful immune support.
-
Barley: Dietary fiber, heart health.
-
Mushrooms: Some immune support.
-
Oats: Lowers cholesterol, heart health.
💊 Uses & Benefits
✅ Taken by Mouth
-
High cholesterol (blocks cholesterol absorption)
-
Diabetes (stabilizes blood sugar, improves insulin sensitivity)
-
Immune support (activates macrophages & neutrophils)
-
Cold & flu, allergies, asthma
-
Autoimmune & inflammatory conditions: RA, Crohn's, fibromyalgia
-
Aging & chronic fatigue
✅ Applied on Skin
-
Wounds, burns, bedsores
-
Eczema, dermatitis, diabetic ulcers
-
Radiation burns, wrinkles
✅ Injected by Healthcare Providers
🍽 In Food Industry
Used as an additive in:
-
Salad dressings, sour cream
-
Cheese spreads, frozen desserts
📊 Dosage Guidelines
By Mouth:
Intravenous (by healthcare provider):
⚠️ Side Effects
Oral:
Injectable:
-
Common: Fever, chills, headache, nausea, dizziness, site pain
-
Rare: Rash, BP changes, thick skin (AIDS patients)
⚠️ Warnings & Precautions
🚫 Drug Interactions
Avoid with immunosuppressants:
-
Prednisone, cyclosporine, tacrolimus, etc.
-
Beta glucan may reduce their effectiveness by stimulating the immune system.
📌 Key Points
-
No strong evidence supports “micronized” beta glucan absorption claims.
-
Most effective immune-enhancing form: yeast-derived
-
Effective cholesterol-lowering: oat and barley-derived
Reference & Research:
|
 |
Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189–202 [review]. |
|
Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr 1997;16:46–51. |
|
Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465–74. |
|
Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 1991;265:1833–9. |
|
Wood PJ. Physicochemical properties and physiological effects of the (1----3)(1----4)-beta-D-glucan from oats. Adv Exp Med Biol 1990;270:119–27. |
|
Uusitupa MI, Miettinen TA, Sarkkinen ES, et al. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur J Clin Nutr 1997;51:607–11. |
|
Lia A, Hallmans G, Sandberg AS, et al. Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 1995;62:1245–51. |
|
Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189–202 [review]. |
|
Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 1999;70:208–12. |
|
Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr 1997;16:46–51. |
|
Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465–74. |
|
Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 1992;11:651–9. |
|
Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology2004;39:1441–9. |
|
Czop JK. The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol Immunopathol Res 1986;5:286–96. |
|
Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 1999;41:89–107. |
|
Czop JK, Kay J. Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes. J Exp Med 1991;173:1511–20. |
|
Czop JK, Puglisi AV, Miorandi DZ, Austen KF. Perturbation of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4 production. J Immunol 1988;141:3170–6. |
|
Estrada A, Yun CH, Van Kessel A, et al. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol Immunol 1997;41:991–8. |
|
Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7:715–29 [review]. |
|
Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999;42:61–74. |
|
Di Renzo L, Yefenof E, Klein E. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol 1991;21:1755–8. | |
| | |
